rs58594334

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.3614G>A​(p.Arg1205Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,564,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1205P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.26

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0078059435).
BP6
Variant 16-1209282-G-A is Benign according to our data. Variant chr16-1209282-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 460089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000716 (109/152260) while in subpopulation AFR AF = 0.00257 (107/41580). AF 95% confidence interval is 0.00218. There are 0 homozygotes in GnomAd4. There are 51 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 109 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.3575G>A p.Arg1192Gln missense_variant Exon 17 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.3575G>A p.Arg1192Gln missense_variant Exon 17 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.3614G>A p.Arg1205Gln missense_variant Exon 17 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*1527G>A non_coding_transcript_exon_variant Exon 17 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*3061G>A non_coding_transcript_exon_variant Exon 16 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.3614G>A non_coding_transcript_exon_variant Exon 17 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*1527G>A 3_prime_UTR_variant Exon 17 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*3061G>A 3_prime_UTR_variant Exon 16 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000703
AC:
107
AN:
152146
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00253
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000235
AC:
40
AN:
170532
AF XY:
0.000190
show subpopulations
Gnomad AFR exome
AF:
0.00354
Gnomad AMR exome
AF:
0.000253
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000275
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000130
AC:
184
AN:
1411842
Hom.:
0
Cov.:
31
AF XY:
0.000107
AC XY:
75
AN XY:
699806
show subpopulations
African (AFR)
AF:
0.00296
AC:
96
AN:
32408
American (AMR)
AF:
0.000233
AC:
9
AN:
38700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25466
East Asian (EAS)
AF:
0.0000541
AC:
2
AN:
36998
South Asian (SAS)
AF:
0.0000244
AC:
2
AN:
81870
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38740
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
0.0000558
AC:
61
AN:
1093154
Other (OTH)
AF:
0.000238
AC:
14
AN:
58794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000716
AC:
109
AN:
152260
Hom.:
0
Cov.:
33
AF XY:
0.000685
AC XY:
51
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00257
AC:
107
AN:
41580
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000230
Hom.:
0
Bravo
AF:
0.000929
ESP6500AA
AF:
0.000623
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000176
AC:
20
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Sep 29, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CACNA1H-related disorder Benign:1
Jan 05, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
13
DANN
Benign
0.81
DEOGEN2
Benign
0.082
T;.;.;.
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.082
N
LIST_S2
Benign
0.63
T;T;T;.
MetaRNN
Benign
0.0078
T;T;T;T
MetaSVM
Uncertain
-0.056
T
MutationAssessor
Benign
1.9
L;.;L;L
PhyloP100
1.3
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
0.48
N;.;N;N
REVEL
Benign
0.21
Sift
Benign
0.61
T;.;T;T
Sift4G
Benign
0.73
T;.;T;T
Polyphen
0.015
B;.;B;B
Vest4
0.19
MVP
0.68
ClinPred
0.0027
T
GERP RS
1.3
Varity_R
0.052
gMVP
0.42
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58594334; hg19: chr16-1259282; API